Molecular Characterization of Autoimmune Hepatitis: A Lipidomic Approach
- Sponsor
- Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
- Study ID
- NCT07644936
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Autoimmune Hepatitis
- Non-Alcoholic Fatty Liver Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This is a two-arm, prospective, controlled observational pilot clinical study aimed at characterizing the lipidomic profile and extracellular vesicles (EVs) of patients with autoimmune hepatitis (AIH) compared to patients with non-alcoholic fatty liver disease (NAFLD). A total of 24 adult outpatients will be enrolled at the Hepatology Outpatient Unit of IRCCS "S. de Bellis". Blood samples will be collected by venipuncture to perform lipidomic analyses on red blood cell membranes and serum, and to isolate and characterize EVs. No intervention beyond standard clinical practice will be applied
Key Dates
- First listed
- Jun 12, 2026
- Start date
- Jul 1, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 1, 2027
- Completion
- Jul 1, 2028
Study Design
- Enrollment
- 24 participants (estimated)
Arms
- Arm: Arm A - Autoimmune Hepatitis (AIH)12 adult outpatients with a confirmed diagnosis of autoimmune hepatitis (AIH), attending the Hepatology Outpatient Unit (UOSD Epatopatie) of IRCCS "S. de Bellis".
- Arm: Arm B - Non-Alcoholic Fatty Liver Disease (NAFLD)12 adult outpatients with a confirmed diagnosis of non-alcoholic fatty liver disease (NAFLD), attending the Hepatology Outpatient Unit (UOSD Epatopatie) of IRCCS "S. de Bellis".
Primary Outcome Measure
Lipidomic profile [ Time Frame: At enrollment (single time point - baseline blood draw) ]
Central Contacts
- Maria Notarnicola, biologyst+39 0804994623
- Valentina De Nunzio+39 0804994623
Related Studies
- MRI Based Biomarkers in Pediatric Autoimmune Liver DiseaseRecruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio
- MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver DiseaseRecruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio
- SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver DiseasePHASE2 · Not Yet Recruiting · Justin Ryder · Chicago, Illinois
- Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)PHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland